{"count": 1, "results": [{"_id": "22197148", "pmid": 22197148, "title": "DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.", "journal": "Diabetes Metab", "authors": ["Scheen AJ"], "date": "2012-04-01T00:00:00Z", "doi": "10.1016/j.diabet.2011.11.001", "meta_date_publication": "2012 Apr", "meta_volume": "38", "meta_issue": "2", "meta_pages": "89-101", "score": 50045.652, "text_hl": "Direct comparisons with active @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-lowering comparators in drug-naive @SPECIES_9606 @@@patients@@@ have demonstrated that @GENE_DPP4 @GENE_1803 @@@DPP-4@@@ inhibitors exert slightly less pronounced @<m>DISEASE_Usher_syndrome_type_1C</m> @DISEASE_MESH:C536486 @@@HbA(1c)@@@ reduction than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (with the advantage of better gastrointestinal tolerability) and similar @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-lowering effects as with a @CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@thiazolidinedione@@@ (@CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@TZD@@@; with the advantage of no @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@). ", "citations": {"NLM": "Scheen AJ. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials. Diabetes Metab. 2012 Apr;38(2):89-101. PMID: 22197148", "BibTeX": "@article{22197148, title={DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.}, author={Scheen AJ}, journal={Diabetes Metab}, volume={38}, number={2}, pages={89-101}}"}}]}